
|Articles|November 13, 2018
AAO Gene Therapy Street Team
Advertisement
Karmen Trzupek discusses the complex interpretation of genetic test results
In his gene therapy break with the experts , Mark Pennesi compared genetic testing for IRDs to fishing
Dominik Fischer presents gene therapy proof-of-concept results in choroideremia
Vinit Mahajan explains that RPE65 mutation subtype was unrelated to outcomes in the Luxturna gene therapy trial
Christine Kay summarizes her jam packed session on gene therapy
Birgit Lorenz looks ahead to ISGEDR 2019 where gene therapy will be a major topic
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Metformin use associated with reduced incidence of intermediate AMD
2
Ocumetics reports first-in-human data investigational accommodating IOL in severe vision loss
3
EnVision Summit 2026: Ultimate gathering place for ophthalmic education
4
Sandoz Canada launches aflibercept biosimilar, Enzeevum
5




























